Biotech News
UroGen Pharma to Present at Upcoming Investor Conferences
investors.urogen.com2026-05-07 12:04 EST
PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in May.